Gene therapy clinical trials

Gene: DDC

No list

DDC (dopa decarboxylase)
EnsemblGeneIds (GRCh38): ENSG00000132437
EnsemblGeneIds (GRCh37): ENSG00000132437
OMIM: 107930, Gene2Phenotype
DDC is in 14 panels

1 review

vardha ismail (Wessex Regional Genetics Service)

Recently, the putaminally-delivered construct, Eladocagene exuparvovec has been approved by the European Medicines Agency and by the British Medicines and Healthcare products Regulatory Agency. This now available gene therapy provides for the first time also for AADC deficiency (AADCD) a causal therapy, leading this disorder into a new therapeutic era.
Delivered by Great Ormond Street Hospital
Created: 19 Dec 2023, 3:02 p.m. | Last Modified: 19 Dec 2023, 3:02 p.m.
Panel Version: 0.9

Phenotypes
Ptosis, Oculogyric crises, Poor feeding, Developmental delay, Truncal hypotonia, Limb dystonia, Orofacial dystonia, Autonomic abnormalities excessive sweating

Publications

History Filter Activity

19 Dec 2023, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set penetrance

vardha ismail (Wessex Regional Genetics Service)

gene: DDC was added gene: DDC was added to Gene therapy clinical trials. Sources: Other Mode of inheritance for gene: DDC was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: DDC were set to PMID: 37402126. Penetrance for gene: DDC were set to Complete